Brightgene Bio-medical Technology Co., Ltd.

This early-stage study tested an investigational drug called BGM0504 in 30 non-diabetic adults who were overweight or obese. Participants received multiple doses of the drug or a placebo to check safety and how the body processes it. The main goal was to see if the drug causes an…

This study looked at how an injection called BGM0504 affects stomach emptying and the way two common drugs—metformin (for diabetes) and warfarin (a blood thinner)—are processed in the body. It involved 28 overweight or obese adults. The goal was to understand if BGM0504 changes h…

This study looked at how the body handles BGM0504, a potential treatment for type 2 diabetes and obesity, in people with different levels of kidney function. Researchers compared 34 participants with normal kidneys to those with mild or moderate kidney impairment. The goal was to…